Stay updated on Pediatric MRD+ CD22+ ALL: Inotuzumab Clinical Trial
Sign up to get notified when there's something new on the Pediatric MRD+ CD22+ ALL: Inotuzumab Clinical Trial page.

Latest updates to the Pediatric MRD+ CD22+ ALL: Inotuzumab Clinical Trial page
- Check4 days agoNo Change Detected
- Check11 days agoChange DetectedA new page revision entry 'Revision: v3.6.6' was added to the record history, and the previous revision 'Revision: v3.6.5' was removed from the list, indicating an update to the page's version history.SummaryDifference0.1%

- Check18 days agoNo Change Detected
- Check25 days agoNo Change Detected
- Check32 days agoChange DetectedA new page revision v3.6.5 was added to the history and the previous revision v3.6.4 was removed, indicating a minor update to the Record History view.SummaryDifference0.1%

- Check47 days agoChange DetectedA new history revision 'Revision: v3.6.4' was added to the study record, replacing the previous 'Revision: v3.6.3' entry. This reflects an updated release note in the record history without altering the underlying study data.SummaryDifference0.1%

- Check68 days agoChange DetectedAdds a new revision entry (v3.6.3) to the study's version history and removes the previous revision (v3.6.2) from the list. This update reflects a metadata versioning change in the study record rather than content changes to the study itself.SummaryDifference0.1%

- Check75 days agoChange DetectedNew revision entry v3.6.2 was added to the study history and the previous revision v3.6.0 was removed. This updates the history to reflect the latest version of the page.SummaryDifference0.1%

- Check90 days agoChange DetectedHistorically the study record includes a new recruitment status 'No longer looking for participants', indicating recruitment has stopped. The revision tag has been updated to v3.6.0, replacing the prior v3.5.5 entry.SummaryDifference0.5%

Stay in the know with updates to Pediatric MRD+ CD22+ ALL: Inotuzumab Clinical Trial
Enter your email address, and we'll notify you when there's something new on the Pediatric MRD+ CD22+ ALL: Inotuzumab Clinical Trial page.